These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
56 related items for PubMed ID: 1792942
1. Pamidronate reduces PTH-mediated bone loss in a gene transfer model of hyperparathyroidism in rats. Mitlak BH, Rodda CP, Von Deck MD, Dobrolet NC, Neer RM, Nussbaum SR. J Bone Miner Res; 1991 Dec; 6(12):1317-21. PubMed ID: 1792942 [Abstract] [Full Text] [Related]
2. Accuracy, precision, and utility of spine and whole-skeleton mineral measurements by DXA in rats. Mitlak BH, Schoenfeld D, Neer RM. J Bone Miner Res; 1994 Jan; 9(1):119-26. PubMed ID: 8154305 [Abstract] [Full Text] [Related]
3. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial. Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G. J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196 [Abstract] [Full Text] [Related]
4. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial. Monegal A, Guañabens N, Suárez MJ, Suárez F, Clemente G, García-González M, De la Mata M, Serrano T, Casafont F, Tome S, Barrios C, Navasa M. Transpl Int; 2009 Feb; 22(2):198-206. PubMed ID: 18796000 [Abstract] [Full Text] [Related]
5. Anabolic effects of recombinant human parathyroid hormone (1 - 84) and synthetic human parathyroid hormone (1 - 34) on the mandibles of osteopenic ovariectomized rats with maxillary molar extraction. Kawane T, Takahashi S, Saitoh H, Okamoto H, Kubodera N, Horiuchi N. Horm Metab Res; 2002 Jun; 34(6):293-302. PubMed ID: 12173069 [Abstract] [Full Text] [Related]
6. Intermittent administration of bovine PTH-(1-34) increases serum 1,25-dihydroxyvitamin D concentrations and spinal bone density in senile (23 month) rats. Mitlak BH, Williams DC, Bryant HU, Paul DC, Neer RM. J Bone Miner Res; 1992 May; 7(5):479-84. PubMed ID: 1615756 [Abstract] [Full Text] [Related]
7. Parenteral pamidronate prevents thyroid hormone-induced bone loss in rats. Rosen HN, Sullivan EK, Middlebrooks VL, Zeind AJ, Gundberg C, Dresner-Pollak R, Maitland LA, Hock JM, Moses AC, Greenspan SL. J Bone Miner Res; 1993 Oct; 8(10):1255-61. PubMed ID: 8256663 [Abstract] [Full Text] [Related]
8. Effect of pamidronate on bone loss after kidney transplantation: a randomized trial. Walsh SB, Altmann P, Pattison J, Wilkie M, Yaqoob MM, Dudley C, Cockwell P, Sweny P, Banks LM, Hall-Craggs M, Noonan K, Andrews C, Cunningham J. Am J Kidney Dis; 2009 May; 53(5):856-65. PubMed ID: 19393473 [Abstract] [Full Text] [Related]
9. Dual-energy x-ray absorptiometry of the rat: accuracy, precision, and measurement of bone loss. Griffin MG, Kimble R, Hopfer W, Pacifici R. J Bone Miner Res; 1993 Jul; 8(7):795-800. PubMed ID: 8352062 [Abstract] [Full Text] [Related]
10. Inhibition of bone resorption by pamidronate cannot restore normal gain in cortical bone mass and strength in tail-suspended rapidly growing rats. Kodama Y, Nakayama K, Fuse H, Fukumoto S, Kawahara H, Takahashi H, Kurokawa T, Sekiguchi C, Nakamura T, Matsumoto T. J Bone Miner Res; 1997 Jul; 12(7):1058-67. PubMed ID: 9200005 [Abstract] [Full Text] [Related]
11. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944 [Abstract] [Full Text] [Related]
12. Parathyroid hormone (1-34) increased total body bone mass in aged female rats. Simmons HA, Pirie CM, Thompson DD, Ke HZ. J Pharmacol Exp Ther; 1998 Jul; 286(1):341-4. PubMed ID: 9655878 [Abstract] [Full Text] [Related]
13. Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain. Yano S, Sugimoto T, Tsukamoto T, Yamaguchi T, Hattori T, Sekita KI, Kaji H, Hattori S, Kobayashi A, Chihara K. Horm Metab Res; 2003 Apr; 35(4):259-64. PubMed ID: 12778370 [Abstract] [Full Text] [Related]
14. Lumbar spine bone mineral density changes in patients with primary hyperparathyroidism according to age and gender. Lumachi F, Camozzi V, Ermani M, Nardi A, Luisetto G. Ann N Y Acad Sci; 2007 Nov; 1117():362-6. PubMed ID: 17656570 [Abstract] [Full Text] [Related]
15. Human parathyroid hormone 1-34 prevents bone loss in experimental biliary cirrhosis in rats. Dresner-Pollak R, Gabet Y, Steimatzky A, Hamdani G, Bab I, Ackerman Z, Weinreb M. Gastroenterology; 2008 Jan; 134(1):259-67. PubMed ID: 18061175 [Abstract] [Full Text] [Related]
16. Site-specific effects of cerivastatin on bone in male Sprague-Dawley rats. Banu J, Kalu DN. Bone; 2004 Mar; 34(3):432-42. PubMed ID: 15003791 [Abstract] [Full Text] [Related]
17. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone. Liu CC, Kalu DN, Salerno E, Echon R, Hollis BW, Ray M. J Bone Miner Res; 1991 Oct; 6(10):1071-80. PubMed ID: 1796755 [Abstract] [Full Text] [Related]
18. Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium. Price RI, Gutteridge DH, Stuckey BG, Kent GN, Retallack RW, Prince RL, Bhagat CI, Johnston CA, Nicholson GC, Stewart GO. J Bone Miner Res; 1993 Feb; 8(2):209-17. PubMed ID: 8442439 [Abstract] [Full Text] [Related]
19. In vivo whole body and appendicular bone mineral density in rats: a dual energy X-ray absorptiometry study. Karahan S, Kincaid SA, Lauten SD, Wright JC. Comp Med; 2002 Apr; 52(2):143-51. PubMed ID: 12022394 [Abstract] [Full Text] [Related]
20. Precise measurement of bone mineral density in rats using dual-energy X-ray absorptiometry. Ladizesky MG, Zeni SN, Mautalén CA. Acta Physiol Pharmacol Ther Latinoam; 1994 Apr; 44(1-2):30-5. PubMed ID: 7640402 [Abstract] [Full Text] [Related] Page: [Next] [New Search]